3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
13
Terminated
3
Unknown
2
Withdrawn
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Carcinoma, Hepatocellular
16
Liver Neoplasms
7
Pancreatic Neoplasms
4
Cholangiocarcinoma
4
Colorectal Neoplasms
3
Thyroid Nodule
2
Thyroid Diseases
2
Neoplasm Metastasis
2
Gallbladder Neoplasms
2
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Stomach Neoplasms
1
Solid Tumor Including Thyroid, Bone, Liver, Pancreas
1
Recurrence
1
Papillary Thyroid Microcarcinoma
1
Neoplasms, Glandular and Epithelial
1
Neoplasms
1
NSCLC
1
Lung Neoplasms
1
Hypertension, Portal
1
Hyperaldosteronism
1
Hepatitis B
1
Hepatic Metastasis of Colorectal Cancer
1
Head and Neck Neoplasms
1
HCC
1
Colorectal Cancer Liver Metastases
1
Colonic Neoplasms
1
Cholestasis
1
Carcinoma, Non-Small-Cell Lung
1
Cancer Pain
1
Interventions
Fluorouracil
18
Oxaliplatin
17
Capecitabine
16
Leucovorin
13
Cisplatin
12
Gemcitabine
11
Drug Therapy
11
Irinotecan
10
Radiosurgery
9
Cetuximab
9
Bevacizumab
9
pembrolizumab
8
Docetaxel
8
Everolimus
7
spartalizumab
6
Sunitinib
6
Radiotherapy
6
Paclitaxel
6
Neoadjuvant Therapy
6
Cyclophosphamide
6
Trastuzumab
5
S 1 (combination)
5
Nivolumab
5
Immunotherapy
5
Immune Checkpoint Inhibitors
5
Chemotherapy, Adjuvant
5
Carboplatin
5
palbociclib
4
manganese chloride
4
Surgical Procedures, Operative
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Neoplasm Metastasis
×
Radiofrequency Ablation
×
Clear all
NCT04574245
2022-10-05
RECORD
Chinese PLA General Hospital
Unknown
3,000 enrolled
NCT03223142
2017-07-21
SMTATS
Shanghai Zhongshan Hospital
Phase NA
Unknown
100 enrolled